Robot assisted radical prostatectomy for elderly patients with high risk prostate cancer. (Q51543755)

6 April 2018

title

Robot assisted radical prostatectomy for elderly patients with high risk prostate cancer. (English)

1 reference

6 April 2018

6

Mani Menon

1 reference

6 April 2018

author name string

Craig G Rogers

1

1 reference

6 April 2018

Jesse D Sammon

2

1 reference

6 April 2018

Shyam Sukumar

3

1 reference

6 April 2018

Mireya Diaz

4

1 reference

6 April 2018

James Peabody

5

1 reference

6 April 2018

publication date

30 July 2011

1 reference

6 April 2018

published in

Urologic Oncology

1 reference

6 April 2018

volume

31

1 reference

6 April 2018

issue

2

1 reference

6 April 2018

page(s)

193-197

1 reference

6 April 2018

Management of localized prostate cancer in senior adults: the crucial role of comorbidity

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.11.018

Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.11.018

Impact of Patient Age on Biochemical Recurrence Rates Following Radical Prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.11.018

Prostate cancer disease-free survival after radical retropubic prostatectomy in patients older than 70 years compared to younger cohorts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.11.018

Impact of patient age at treatment on outcome following radical retropubic prostatectomy for prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.11.018

Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.11.018

Robot-assisted radical prostatectomy in men aged > or =70 years.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.11.018

Robotic radical prostatectomy for elderly patients: probability of achieving continence and potency 1 year after surgery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.11.018

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.11.018

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.11.018

Vattikuti Institute prostatectomy: technical modifications in 2009.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.11.018

Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.11.018

Age and grade trends in prostate cancer (1974-2003): a Surveillance, Epidemiology, and End Results Registry analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.11.018

20-year outcomes following conservative management of clinically localized prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.11.018

Age stratified functional outcomes after laparoscopic radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.11.018

Radical prostatectomy for clinically localized, high risk prostate cancer: critical analysis of risk assessment methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.11.018

Long-term outcome following radical prostatectomy in men with clinical stage T3 prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.11.018

Intermediate-Term Potency, Continence, and Survival Outcomes of Radical Prostatectomy for Clinically High-Risk or Locally Advanced Prostate Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.11.018

Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.11.018

Radical prostatectomy as primary treatment modality for locally advanced prostate cancer: a prospective analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.11.018

A retrospective study of the treatment of locally advanced prostate cancer by six institutions in eastern and north-eastern Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.11.018

Neoadjuvant therapy before radical prostatectomy for clinical T3/T4 carcinoma of the prostate: 5-year followup, Phase II Southwest Oncology Group Study 9109.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.11.018

National practice patterns and time trends in androgen ablation for localized prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.11.018

Radical prostatectomy for pathological Gleason 8 or greater prostate cancer: influence of concomitant pathological variables

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.11.018

Is there age bias in the treatment of localized prostate carcinoma?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.11.018

Continued undertreatment of older men with localized prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.11.018

Cause of death in older men after the diagnosis of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.11.018

A Competing-Risks Analysis of Survival After Alternative Treatment Modalities for Prostate Cancer Patients: 1988–2006

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.11.018

10.1016/J.UROLONC.2010.11.018

7 January 2021

Identifiers

DOI

1 reference

6 April 2018

PubMed ID

21803614

1 reference

6 April 2018